We are live on
!
Find out more
PP
PDT Partners Portfolio holdings
AUM
$1.69B
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
+6.28%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.31B
AUM Growth
-$78.9M
(-5.7%)
Cap. Flow
-$105M
Cap. Flow
% of AUM
-7.96%
Top 10 Holdings %
Top 10 Hldgs %
6.88%
Holding
1,081
New
330
Increased
200
Reduced
286
Closed
229
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALLK
Allakos
ALLK
|
+$7.87M |
| 2 |
UiPath
PATH
|
+$6.99M |
| 3 |
Marqeta
MQ
|
+$6.41M |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$5.72M |
| 5 |
FIGS
FIGS
|
+$5.31M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MongoDB
MDB
|
+$7M |
| 2 |
Charles River Laboratories
CRL
|
+$6.37M |
| 3 |
Floor & Decor
FND
|
+$5.83M |
| 4 |
Bruker
BRKR
|
+$5.34M |
| 5 |
Asana
ASAN
|
+$5.32M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.86% |
| 2 | Healthcare | 21.49% |
| 3 | Industrials | 12.78% |
| 4 | Consumer Discretionary | 11.8% |
| 5 | Financials | 9.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Ecovyst
ECVT
$1.35B
| $135K | 0.01% |
+13,148
| New | +$144K |
|
|
BIOC
802
DELISTED
Biocept, Inc.
BIOC
| $130K | 0.01% |
+1,197
| New | +$138K |
|
803
Precigen
PGEN
$1.97B
| $125K | 0.01% |
+33,684
| New | +$145K |
|
|
BFIN
804
DELISTED
BankFinancial
BFIN
| $124K | 0.01% |
+11,598
| New | +$129K |
|
805
Quad
QUAD
$434M
| $122K | 0.01% |
30,587
-1,415
| -4% | -$5.79K |
|
|
PRVB
806
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $122K | 0.01% |
+21,786
| New | +$138K |
|
807
Antero Midstream
AM
$10.3B
| $120K | 0.01% |
+12,400
| New | +$129K |
|
808
Rafael Holdings
RFL
$109M
| $117K | 0.01% |
+23,323
| New | +$314K |
|
809
Rayonier Advanced Materials
RYAM
$591M
| $117K | 0.01% |
+20,576
| New | +$134K |
|
|
DSKE
810
DELISTED
Daseke, Inc. Common Stock
DSKE
| $117K | 0.01% |
+11,645
| New | +$114K |
|
|
HOOK
811
DELISTED
HOOKIPA Pharma
HOOK
| $115K | 0.01% |
4,930
| – | – |
|
812
VirTra
VTSI
$33.9M
| $115K | 0.01% |
16,360
-1,764
| -10% | -$14K |
|
|
SQZ
813
DELISTED
SQZ Biotechnologies Company
SQZ
| $114K | 0.01% |
+12,777
| New | +$157K |
|
814
ARS Pharmaceuticals
SPRY
$563M
| $112K | 0.01% |
16,881
+1,289
| +8% | +$10.5K |
|
815
Pixelworks
PXLW
$37.2M
| $111K | 0.01% |
+2,107
| New | +$119K |
|
816
Alpha Pro Tech
APT
$51.1M
| $110K | 0.01% |
+18,344
| New | +$107K |
|
817
Daktronics
DAKT
$953M
| $108K | 0.01% |
21,445
-3,676
| -15% | -$19.3K |
|
818
Hudbay
HBM
$9.67B
| $107K | 0.01% |
14,715
-27,863
| -65% | -$193K |
|
819
Navigator Holdings
NVGS
$1.34B
| $104K | 0.01% |
11,700
-4,927
| -30% | -$43.2K |
|
820
Quantum Corp
QMCO
$444M
| $103K | 0.01% |
936
-2,619
| -74% | -$299K |
|
|
ABST
821
DELISTED
Absolute Software Corp
ABST
| $101K | 0.01% |
+10,735
| New | +$109K |
|
822
Verrica Pharmaceuticals
VRCA
$92.8M
| $99K | 0.01% |
+1,080
| New | +$122K |
|
823
Greenlight Captial
GLRE
$586M
| $98K | 0.01% |
12,439
-6,561
| -35% | -$48.1K |
|
|
MCBC
824
DELISTED
Macatawa Bank Corp
MCBC
| $98K | 0.01% |
11,100
| – | – |
|
825
Axogen
AXGN
$2.19B
| $97K | 0.01% |
+10,352
| New | +$124K |
|
Similar funds
ISS
GAM
BCM
FACM
TCBWMS
SGI
AAM
RSCM
PDT Partners's Q4 2021 Portfolio in Review
As of Q4 2021, PDT Partners held 1,081 positions worth $1.31B, down 5.7% from $1.39B the previous quarter. Its ten largest holdings account for 6.9% of the portfolio.
PDT Partners withdrew a net $105M in Q4 2021, closing 229 positions and reducing 286 holdings. Its most notable exit was MongoDB, an estimated $7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, PDT Partners opened a new position in Allakos worth $940K.
- PDT Partners's largest Q4 2021 buy was Allakos: 96,046 shares worth $940K.
- PDT Partners added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2021, an estimated $5.72M increase.
- PDT Partners's biggest Q4 2021 reduction was Charles River Laboratories, cutting an estimated $6.37M.
- PDT Partners fully exited MongoDB in Q4 2021, selling an estimated $7M.
- PDT Partners's ten largest holdings make up 6.9% of its $1.31B portfolio in Q4 2021.
- PDT Partners opened 330 new positions and closed 229 in Q4 2021.
- PDT Partners's portfolio value fell 5.7% quarter-over-quarter to $1.31B.
Based on PDT Partners's 13F filing for Q4 2021, filed 14 Feb 2022.